328 related articles for article (PubMed ID: 10398598)
1. A nucleoside transporter from Trypanosoma brucei involved in drug resistance.
Mäser P; Sütterlin C; Kralli A; Kaminsky R
Science; 1999 Jul; 285(5425):242-4. PubMed ID: 10398598
[TBL] [Abstract][Full Text] [Related]
2. A drug resistance determinant in Trypanosoma brucei.
Carter NS; Barrett MP; de Koning HP
Trends Microbiol; 1999 Dec; 7(12):469-71. PubMed ID: 10603477
[No Abstract] [Full Text] [Related]
3. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of trypanocides by functional expression of an adenosine transporter from Trypanosoma brucei in yeast.
Mäser P; Vogel D; Schmid C; Räz B; Kaminsky R
J Mol Med (Berl); 2001 Apr; 79(2-3):121-7. PubMed ID: 11357935
[TBL] [Abstract][Full Text] [Related]
5. The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.
de Koning HP; Anderson LF; Stewart M; Burchmore RJ; Wallace LJ; Barrett MP
Antimicrob Agents Chemother; 2004 May; 48(5):1515-9. PubMed ID: 15105099
[TBL] [Abstract][Full Text] [Related]
6. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter.
de Koning HP; Jarvis SM
Acta Trop; 2001 Dec; 80(3):245-50. PubMed ID: 11700182
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.
Matovu E; Geiser F; Schneider V; Mäser P; Enyaru JC; Kaminsky R; Gallati S; Seebeck T
Mol Biochem Parasitol; 2001 Sep; 117(1):73-81. PubMed ID: 11551633
[TBL] [Abstract][Full Text] [Related]
8. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
Carter NS; Fairlamb AH
Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
[TBL] [Abstract][Full Text] [Related]
9. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei.
Carter NS; Berger BJ; Fairlamb AH
J Biol Chem; 1995 Nov; 270(47):28153-7. PubMed ID: 7499305
[TBL] [Abstract][Full Text] [Related]
10. Effects of intermediates of methionine metabolism and nucleoside analogs on S-adenosylmethionine transport by Trypanosoma brucei brucei and a drug-resistant Trypanosoma brucei rhodesiense.
Goldberg B; Rattendi D; Lloyd D; Sufrin JR; Bacchi CJ
Biochem Pharmacol; 1998 Jul; 56(1):95-103. PubMed ID: 9698093
[TBL] [Abstract][Full Text] [Related]
11. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.
Suswam EA; Taylor DW; Ross CA; Martin RJ
Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599
[TBL] [Abstract][Full Text] [Related]
12. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.
Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP
Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.
Matovu E; Seebeck T; Enyaru JC; Kaminsky R
Microbes Infect; 2001 Jul; 3(9):763-70. PubMed ID: 11489425
[TBL] [Abstract][Full Text] [Related]
14. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
Witola WH; Inoue N; Ohashi K; Onuma M
Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.
Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP
J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.
Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP
Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978
[TBL] [Abstract][Full Text] [Related]
17. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.
Barrett MP; Fairlamb AH
Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334
[TBL] [Abstract][Full Text] [Related]
18. Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.
Lüscher A; Onal P; Schweingruber AM; Mäser P
Antimicrob Agents Chemother; 2007 Nov; 51(11):3895-901. PubMed ID: 17698621
[TBL] [Abstract][Full Text] [Related]
19. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
[TBL] [Abstract][Full Text] [Related]
20. Uptake and mode of action of drugs used against sleeping sickness.
Denise H; Barrett MP
Biochem Pharmacol; 2001 Jan; 61(1):1-5. PubMed ID: 11137702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
